𝔖 Bobbio Scriptorium
✦   LIBER   ✦

SMI-31 Immunoreactivity in inclusion body myositis

✍ Scribed by Simone Spuler; Andrew G. Engel


Publisher
John Wiley and Sons
Year
1997
Tongue
English
Weight
140 KB
Volume
42
Category
Article
ISSN
0364-5134

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Apolipoprotein E Ο΅4 in inclusion body my
✍ Michael J. Garlepp; Hyacinth Tabarias; Frank M. van Bockxmeer; Paul J. Zilko; Be πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 313 KB πŸ‘ 1 views
Intracellular phosphates in inclusion bo
✍ Zohar Argov; Tanja Taivassalo; Nicola De Stefano; Angela Genge; George Karpati; πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 76 KB πŸ‘ 2 views

Muscle phosphorus magnetic resonance spectroscopy was used to study oxidative metabolism at rest and during recovery from exercise in 7 patients with sporadic inclusion body myositis (s-IBM), compared with normal controls (n = 8) and mitochondrial myopathies (n = 20). At rest, 6/7 patients had eleva

Quantitative electrophysiologic studies
✍ Paul E. Barkhaus; M. Isabel Periquet; Sanjeev D. Nandedkar πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 235 KB πŸ‘ 2 views

Sporadic inclusion body myositis (S-IBM) is a progressive, acquired disease of unknown etiology. Prior studies have suggested neurogenic involvement based on electrophysiologic data, although the biopsy is compatible with a myopathic process. Quantitative electrophysiologic studies were performed in

Prevalence of sporadic inclusion body my
✍ Beverley A. Phillips; Paul J. Zilko; Frank L. Mastaglia πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 114 KB πŸ‘ 2 views

A 10-year retrospective review was conducted to ascertain the prevalence of inclusion body myositis (IBM) in Western Australia. Seventeen patients with sporadic IBM aged 45-90 years were identified and the prevalence of IBM was calculated to be 9.3 Γ— 10 -6 . The prevalence was higher in men (10.9 Γ—